These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 7835913)

  • 1. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
    Haviland DL; McCoy RL; Whitehead WT; Akama H; Molmenti EP; Brown A; Haviland JC; Parks WC; Perlmutter DH; Wetsel RA
    J Immunol; 1995 Feb; 154(4):1861-9. PubMed ID: 7836770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
    Zahn S; Zwirner J; Spengler HP; Götze O
    Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
    Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
    J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
    Wilmer WA; Kaumaya PT; Ember JA; Cosio FG
    J Immunol; 1998 Jun; 160(11):5646-52. PubMed ID: 9605171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma).
    Sprott H; Müller-Ladner U; Distler O; Gay RE; Barnum SR; Landthaler M; Schölmerich J; Lang B; Gay S
    J Rheumatol; 2000 Feb; 27(2):402-4. PubMed ID: 10685805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
    Elsner J; Oppermann M; Kapp A
    Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
    Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
    Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T cells express the C5a receptor and are chemoattracted to C5a.
    Nataf S; Davoust N; Ames RS; Barnum SR
    J Immunol; 1999 Apr; 162(7):4018-23. PubMed ID: 10201923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic peptides against human anaphylatoxin C5a.
    Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H
    Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
    Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
    J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.